Cyclobutylamine → N-tert-Butyl-3-((4-(4-(3-cyclobutylureido)-2,5-difluorobenzoyl)piperazin-1-yl)methyl)-benzamide
Reaction equation
[NH2:1][C:2]1[C:29]([F:30])=[CH:28][C:5]([C:6]([N:8]2[CH2:13][CH2:12][N:11]([CH2:14][C:15]3[CH:16]=[C:17]([CH:25]=[CH:26][CH:27]=3)[C:18]([NH:20][C:21]([CH3:24])([CH3:23])[CH3:22])=[O:19])[CH2:10][CH2:9]2)=[O:7])=[C:4]([F:31])[CH:3]=1.Cl[C:33](OC1C=CC([N+]([O-])=O)=CC=1)=[O:34].[CH:45]1([NH2:49])[CH2:48][CH2:47][CH2:46]1>ClCCl.O>[C:21]([NH:20][C:18](=[O:19])[C:17]1[CH:25]=[CH:26][CH:27]=[C:15]([CH2:14][N:11]2[CH2:10][CH2:9][N:8]([C:6](=[O:7])[C:5]3[CH:28]=[C:29]([F:30])[C:2]([NH:1][C:33]([NH:49][CH:45]4[CH2:48][CH2:47][CH2:46]4)=[O:34])=[CH:3][C:4]=3[F:31])[CH2:13][CH2:12]2)[CH:16]=1)([CH3:24])([CH3:23])[CH3:22]Participants
6
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
3-((4-(4-Amino-2,5-difluorobenzoyl)piperazin-1-yl)methyl)-N-tert-butylbenzamide (1 g, 0.023 mol) and 4-nitrophenol chloroformate (0.4636 g, 0.0023 mol) were combined and stirred in dichloromethane for 1 hour at room temperature. Cyclobutylamine (0.8969 g, 0.0017 mol, 0.108 mL) was added and the reaction was stirred for 30 minutes. The reaction mixture was diluted with water and flushed through a hydrophobic frit. The organic phase was concentrated under vacuum and purified by acidic reverse phase HPLC to afford the title compound (21 mg).
Workup
- customflushed through a hydrophobic frit
- concentrationThe organic phase was concentrated under vacuum
- custompurified by acidic reverse phase HPLC
Sources & evidence
- ORD record
- ord-47f323ff7d404814a03c9ed506a6ca5c
- Source dataset
- uspto-grants-2012_11
- Patent number
- US08314091B2
Reaction notes
Loading…